Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical ApproachByDell B. Mather, PharmD,Sean D. Sullivan, PhD,Darren Augenstein, PharmD, MBA,D. S. Pete Fullerton, PhD, RPh,Debbie Atherly, RPh, MPHMarch 1st 1999
Economic Impact of Delaying or Preventing AIDS in Persons with HIVBySteven D. Pinkerton, PhD,David R. Holtgrave, PhDMarch 1st 1999
Dissecting Cost-Effectiveness Analysis for Preventive Interventions: A Guide for Decision MakersBySteven M. Teutsch, MD, MPH,James F. Murray, PhDMarch 1st 1999
Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The IssuesByHoward Fillit, MD,David Knopman, MD,Jeffrey Cummings, MD,Frank Appel, MS,for the Alzheimer's Disease Managed Care Advisory CouncilMarch 1st 1999
Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for CareByHoward Fillit, MD,David Knopman, MD,Jeffrey Cummings, MD,Frank Appel, MS,for the Alzheimer's Disease Managed Care Advisory CouncilMarch 1st 1999
Erectile Dysfunction: The Primary Care Practitioner's ViewByRichard Sadovsky, MD,Marian Dunn, PhD,B. Mayer Grobe, MDMarch 1st 1999
Evidence-Based Decision Making: Using Submission Guidelines to Inform Formulary ApprovalsByAslam H. Anis, PhDMarch 1st 1999
Correspondence regarding, "Clinic Visits and Hospital Admissions for Care of Acid-related Upper Gastrointestinal Disorders in Women Using Alendronate for Osteoporosis"ByA. John Yates, MD,Author reply by Bruce Ettinger, MDMarch 1st 1999
Correspondence regarding, "Insurance Type and the Transportation to Emergency Departments of Patients With Acute Cardiac Ischemia"ByRobert A. Lowe, MD, MPH,Author reply by Harry P. Selker, MD,Harold A. Picken, MD,Joni R. Beshansky, RN, MPH,John L. Griffith, PhDMarch 1st 1999